Cassava Sciences | PTIE - Loan Capital


Cassava Sciences reported $0 in Loan Capital for its fiscal quarter ending in December of 2024.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Amgen USD 50B 2.43B Dec/2025
Biogen USD 6.29B 1.4M Sep/2025
Cara Therapeutics USD 0 0 Mar/2025
Cassava Sciences USD 0 0 Dec/2024
Eisai JPY 134.77B 12M Dec/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Geron USD 119.55M 283K Dec/2025
J&J USD 39.44B 30M Dec/2025
Merck USD 39.97B 6B Sep/2025
Novartis USD 29.59B 5.35B Dec/2025
Novavax USD 246.3M 200K Dec/2025
Pfizer USD 57.41B 93M Sep/2025
Roche Holding CHF 27.43B 966M Dec/2025